Proximal humerus fractures are common, and most of them occur in elderly patients. The incidence in Finland was reported to be 105 per 10^5^ person-years in 2002 ([@CIT0022]), but this varies depending on the geographic area ([@CIT0011], [@CIT0005]). The number of proximal humerus fractures has increased during the last few decades. As the population ages, the number of proximal humerus fractures would be expected to increase further ([@CIT0022]).

Proximal humerus fractures are often displaced and comminuted in the elderly. The treatment method varies between countries, hospitals, and different surgeons. The popularity of plate fixation has increased in Finland with no real evidence to support it ([@CIT0013]).

The literature on proximal humerus fractures is vast, but there has been little high-quality research comparing different treatments. There have been a few randomized controlled trials (RCTs), but rather than giving exact answers, these studies appear to have raised even more questions. Because previous systematic reviews ([@CIT0015], Sproulet al. 2011, [@CIT0002]) and the latest Cochrane review ([@CIT0012]) have not included the RCTs published in recent years, we wanted to evaluate all of the relevant literature and to summarize the current evidence-based knowledge on the treatment of proximal humeral fractures in the elderly. Moreover, the above reviews did not concentrate on the troublesome osteoporotic fractures. We assessed the effect of operative treatment on function and/or disability and complications of different treatments in elderly patients with proximal humeral fractures.

Materials and methods {#ss1}
=====================

We conducted a systematic search of the following electronic databases, without language restrictions, covering the years 1946 to 2012: Ovid MEDLINE and the Scopus database, which includes Embase. The last search was carried out on April 30, 2014. The search terms were: "shoulder fractures", "proximal humeral fracture", and "rehabilitation, surgery, therapy". The detailed MESH terms are given in the [appendix](#s1){ref-type="supplementary-material"} (see Supplementary data).

The abstracts of the publications retrieved were manually checked and relevant publications were selected for further analysis. Reviews, trial protocols, and retrospective studies were excluded. In the next phase, full articles were obtained for all potentially relevant papers, to determine whether they fulfilled the inclusion criteria. The PICOS principle was used to determine the inclusion and exclusion criteria ([Table 1](#T1){ref-type="table"}). These phases were performed independently by 3 authors. Any discrepancies regarding the inclusion criteria were settled by negotiation between the authors.

###### 

PICOS criteria for the trials included

  ---------------- ---------------------------------------------------------------------------------------------------------
  Patients:        Age 60 years or older with a 2-, 3-, or 4-part proximal humerus fracture due to recent trauma
  Intervention:    Any operative treatment (at least 20 patients in each treatment group)
  Control:         Any treatment (at least 20 patients in each treatment group)
  Outcome:         Any functional or disability score and/or any quality-of-life score after a minimum follow-up of 1 year
  Study setting:   Randomized, controlled trial or controlled clinical trial
  ---------------- ---------------------------------------------------------------------------------------------------------

Data extraction and quality assessment {#ss2}
--------------------------------------

The data in the studies were evaluated by 1 author using a predefined data sheet. The extraction was checked independently by 2 other authors; thus, each citation was checked at least twice. We collected information on study design and descriptive data, such as the fracture classification used, types of treatment in the intervention and control groups, group sizes, drop-out rates, and patient demographics; the effects of treatment, including primary and secondary outcomes, reported complications, and reoperation rate; and study quality, including the criteria for the risk of bias. The risk of bias was assessed as suggested by [@CIT0010]. The risk of bias was considered to be low when 6 or more criteria out of 12 were met, and the risk was rated as high when less than 6 out of 12 criteria were met. During this assessment, we contacted each main author (n = 8) in order to obtain additional information and clarification if there was inadequate reporting in the publication. 5 of the authors replied to queries regarding missing information on randomization, allocation, and baseline group similarities. With the additional information from the authors, the analysis of bias risk was complete. In addition, the potential conflicts of interests reported by the authors were documented.

Results {#ss3}
=======

After eliminating duplicates, the database search resulted in 777 abstracts. 9 papers met the inclusion criteria and were accepted for review ([Figure 1](#F1){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). 692 abstracts did not meet the inclusion criteria and were excluded, due to being retrospective in design or to lacking a control group.

![Flow chart of publications investigated, from search for abstracts to final analysis.](ORT-86-280-g001){#F1}

###### 

Study designs

  A            B                                        C     D       E              F                                               G                          H    I       J    K    L
  ------------ ---------------------------------------- ----- ------- -------------- ----------------------------------------------- -------------------------- ---- ------- ---- ---- ---
  [@CIT0027]   Sweden                                   RCT   3(-4)                  Tension band (20)                               Nonoperative (20)          12   40/38   73   75   2
  [@CIT0007]   Austria                                  RCT   4       11-C           Hemiarthroplasty                                Hemiarthroplasty           12   40/35   74   73   5
                                                                                     (Epoca (20))                                    (HAS (20))                                        
  [@CIT0008]   Norway[**^b^**](#T2-F2){ref-type="fn"}   RCT   3-4     11-B2, 11-C2   Plating [**^a^**](#T2-F1){ref-type="fn"} (25)   Nonoperative (25)          12   50/48   72   73   2
  [@CIT0019]   Sweden                                   RCT   4                      Hemiarthroplasty                                Nonoperative (28)          24   55/49   76   78   6
                                                                                     (Global FX (27))                                                                                  
  [@CIT0020]   Sweden                                   RCT   3                      Plating (Philos (30))                           Nonoperative (30)          24   60/53   73   75   7
  [@CIT0026]   Germany                                  RCT   3-4                    Plating (humeral                                Plating (Philos (31))      12   56/48   76   72   8
                                                                                     suture plate (25))                                                                                
  [@CIT0008]   Norway[**^b^**](#T2-F2){ref-type="fn"}   RCT   3-4     11-B2, 11-C2   Plating [**^a^**](#T2-F1){ref-type="fn"} (25)   Nonoperative (25)          12   50/48   72   73   2
  [@CIT0001]   Netherlands                              RCT   4                      Hemiarthroplasty                                Nonoperative (25)          12   50/47   76   80   3
                                                                                     (Global FX (25))                                                                                  
  [@CIT0003]   Italy                                    CCT   3-4                    MIROS pinning (31)                              Traditional pinning (27)   24   58/52   78   81   6
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KMean age (control group)

LDrop-out, n

Nonspecific LCT AO-type locking plate.

Both publications are from the same population.

The study populations involved 409 patients. 8 studies were randomized controlled trials (RCTs) and 1 was a controlled clinical trial ([@CIT0003]). In all trials, the patients had a recent 3- or 4-part fracture based on Neer's classification ([@CIT0018]). 6 trials compared operative treatment and nonoperative treatment. [@CIT0026] compared monoaxial and polyaxial constructions in locking plates, [@CIT0007] compared 2 different prostheses, and [@CIT0003] compared 2 different pinning operations. [@CIT0027] compared use of a tension band and conservative treatment. In 3 studies ([@CIT0008], [@CIT0020], [@CIT0009]), locking plates were compared to nonoperative treatment for 3- and 4-part fractures. 2 trials ([@CIT0019], [@CIT0001]) compared prosthesis and nonoperative treatment for 4-part fractures. The study designs and patient populations are given in [Table 2](#T2){ref-type="table"}. [Table 3](#T3){ref-type="table"} summarizes the primary and secondary outcomes.

###### 

Functional results of the trial. Values are mean (SD) unless otherwise stated

                                                Primary outcome measure                                                                           Secondary outcome measure                                                       Adjacent outcome measure                                                                                                                               
  --------------------------------------------- --------------------------------------------------- --------------------------------------------- --------------------------- --------------------------------------------------- --------------------------------------------- ------ --------------------------------------------------- --------------------------------------------- ---------
  [@CIT0027]                                    CS: 60 (19)                                         65 (15)                                       \> 0.05                                                                                                                                                                                                                                
  [@CIT0007]                                    ICS: 70 (38--102)[**^b^**](#T3-F2){ref-type="fn"}   46 (15--80)[**^b^**](#T3-F2){ref-type="fn"}   0.001                       CS: 52 (20--80)[**^b^**](#T3-F2){ref-type="fn"}     33 (8--68)[**^b^**](#T3-F2){ref-type="fn"}    na                                                                                                       
  [@CIT0008] [**^a^**](#T3-F1){ref-type="fn"}   CD: 35 (28--43)[**^b^**](#T3-F2){ref-type="fn"}     33 (26--40)[**^b^**](#T3-F2){ref-type="fn"}   0.6                         ASES: 15 (12--18)[**^a^**](#T3-F1){ref-type="fn"}   16 (13--18)[**^b^**](#T3-F2){ref-type="fn"}   0.7                                                                                                      
  [@CIT0019]                                    EQ: 0.81 (0.12)                                     0.65 (0.27)                                   0.02                        CS: 48 (16)                                         50 (21)                                       0.8    DASH: 30 (18)                                       37 (21)                                       0.3
  [@CIT0020]                                    CS: 61 (19)                                         58 (23)                                       0.6                         DASH: 26 (25)                                       36 (27)                                       0.2    EQ: 0.70 (0.34)                                     0.59 (0.35)                                   0.3
  [@CIT0026]                                    SST: 8 (3)                                          10 (2)                                        0.3                         DASH: 18 (16)                                       16 (12)                                       1.0    CS: 73                                              81                                            \> 0.05
  [@CIT0009] [**^a^**](#T3-F1){ref-type="fn"}   15D: 0.84 (0.11)                                    0.82 (0.08)                                   0.4                                                                                                                                                                                                                                    
  [@CIT0001]                                    CS: 64 (16)                                         60 (18)                                       0.4                         SST: 25 (8--100)                                    23 (0--92)                                    0.6    VAS12: 23 (1--65)[**^c^**](#T3-F3){ref-type="fn"}   25 (1--93) [**^c^**](#T3-F3){ref-type="fn"}   0.7
  [@CIT0003]                                    CS: 60                                              CS: 52                                        0.02                        SSV: 90                                             73                                            0.02                                                                                                     

CS = Constant Score;

ICS = Individual Constant Score determined by comparing the operated shoulder to the patient's unaffected shoulder in percent;

CD = Constant Score difference at 12 months, and to reduce the influence of age, the difference between the scores for the injured and

uninjured shoulders was used;

ASES = American Shoulder and Elbow Surgeons Shoulder Score

EQ = Euroqol-5D

DASH = Disabilities of the Arm, Shoulder, and Hand

SST = Simple Shoulder Test

SSV = Subjective Shoulder Value

VAS12 = Visual Analogue Scale at 12 months, mean (range)

Both publications are from the same population.

Threshold values

Range

3 of the 9 studies had a high risk of bias. They lacked appropriate randomization (e.g. sealed envelopes, random number generation, and/or concealment of allocation) or did not report baseline characteristics in an appropriate way. The remaining 6 studies had a low risk of bias ([Table 4](#s1){ref-type="supplementary-material"}, see Supplementary data).

Outcomes and complications {#ss4}
--------------------------

*Tension band*

[@CIT0027] reported the results of a comparison of tension band and nonoperative treatment after 1-year follow-up. The Constant score (CS) was 60 and 65, respectively, at 1 year, but the difference was reported as not being significant. A 10-point difference in CS has been considered to be clinically significant in rotator-cuff tears ([@CIT0014]).

[@CIT0027] reported a total of 8 complications among patients. In the intervention group, the surgical site infection rate was 2 out of 19. In 1 case, the K-wire penetrated the glenohumeral joint and another patient experienced a pulmonary embolus. In the later phase, 2 patients in the intervention group developed osteoarthritis (1 patient after non-union) and 2 patients in the control group developed osteoarthritis.

*Pinning*

[@CIT0003] reported the results of a comparison of MIROS pinning and traditional pinning after 2 years of follow-up. The MIROS was described as "a new percutaneous pinning device allowing correction of angular displacement and stable fixation of fracture fragments". The mean CS was 60 for MIROS pinning and 52 for traditional pinning, and the mean subjective shoulder evaluation value was 90 vs. 73. Both results were statistically significant in favor of MIROS pinning, but they lacked clinical significance.

[@CIT0003] also reported 3 complications in 28 patients in the MIROS group and 7 complications in 26 patients in the traditional pinning group, including 4 pin-track infections. They did not report any reoperations.

*Locking plate*

[@CIT0008], [@CIT0009]) compared locking plate and nonoperative treatment in 3- and 4-part fractures. The primary outcome was a difference in CS (CSD 12) at 12 months; in order to reduce the influence of age, the difference between the scores of the injured and uninjured shoulder was used. No statistically significant or clinically significant differences were found in any of the following outcomes. The mean CSD12 was 35 and 33 in the surgical and nonoperative treatment groups, respectively, and the mean American Shoulder and Elbow Surgeons shoulder score (ASES) was 15 and 16. In assessing health-related quality of life (HRQoL), mean 15D in the surgery group was 0.84 and it was 0.82 in the nonoperative group.

[@CIT0020] found similar CS in operative and nonoperative groups for 3-part fractures (61 vs. 58). Disabilities of the arm, shoulder, and hand (DASH) (operative 26 vs. nonoperative 36; p = 0.2) and Euroqol-5D (EQ-5D; operative 0.70 vs. nonoperative 0.59; p = 0.3) were similar between groups at 2 years.

[@CIT0026] found no significant differences between polyaxial and monoaxial constructions in locking plates in the simple shoulder test (8.6 vs. 9.7; p = 0.3), DASH (18 vs. 16; p = 1.0), and CS (73 vs. 81; p \> 0.05)

[@CIT0008], [@CIT0009]) reported 1 hardware failure, 7 screw cut-outs, and 2 deaths in 3 months in the surgery group. 4 of the 25 patients needed a reoperation. 1 of the nonoperatively treated patients was operated on later. [@CIT0020] reported screw penetrations in 5 of 30 cases in the primary postoperative period, and 3 additional screw penetrations at 4 months. 1 case of primary postoperative infection was reported, and 1 patient in the nonoperative group had non-union. Altogether, 4 patients died (2 from each group), for reasons not related to surgery. Reoperations were required for 9 of 30 patients in the locking plate group during the 2-year follow-up period. [@CIT0026] reported 6 complications in the intervention (polyaxial) group (n = 20) and 8 in the control (monoaxial) group (n = 28). Reoperations were performed in 6 and 4 cases.

*Hemiarthroplasty*

In the studies comparing hemiarthroplasty with nonoperative treatment, all the patients had 4-part fractures. [@CIT0019] found that the operative group had better mean EQ-5D (0.81) than the nonoperative group (0.62), which was clinically and statistically significant (p = 0.02). However, mean DASH (30 vs. 37; p = 0.3) and CS (48 vs. 50; p = 0.8) were not significant at the 2-year follow-up. [@CIT0001] found no statistically significant differences in mean values for CS (operative treatment 64 vs. nonoperative treatment 60), the simple shoulder test (25 vs. 23), or the visual analog scale (VAS) at 12 months (23 vs. 25).

[@CIT0007] compared 2 prostheses: Epoca (Depuy Synthes) and HAS (Stryker). The individual Constant score (CSindiv) was determined by comparing the operative shoulder to the patient's unaffected shoulder. The CSindiv was 70% and 46% for the Epoca and HAS (p = 0.001), and absolute CS was 52 vs. 33 (p-value not reported) at the 1-year follow-up, with both results favoring the Epoca prosthesis.

[@CIT0019] reported 1 non-union in their nonoperative group (n = 28). Of all 55 patients, 5 died---3 in the operative group (n = 27) and 2 in the nonoperative group (n = 28), and none fracture-related. 3 patients in the operative group required reoperation, and 1 patient in the nonoperative group with non-union received operative treatment. [@CIT0001] reported 4 tuberculum malpositions and 2 greater tubercle non-unions in the operative group. 5 cases of non-union were reported in the nonoperative group (n = 25). 1 patient required reoperation, and the other patient in the nonoperative group was operated on at 13 months. [@CIT0007] reported 2 infections in the operative group (n = 18); these were treated nonoperatively with antibiotics.

Discussion {#ss5}
==========

8 RCTs from 7 study populations and 1 controlled clinical trial---all published between 1946 and April 30, 2014---fulfilled our inclusion criteria. In these trials, there were no significant differences in functional outcomes between surgical treatment with a tension band and nonoperative treatment. Moreover, the complication rate was greater with operative treatment. With locking plate systems, operations did not result in substantial improvement in function or HRQoL scores compared to nonoperative treatment. Furthermore, patients treated operatively had high complication rates (10--29%) and high reoperation rates (16--30%).

In 4-part fractures, HRQoL measured with the EQ-5D was better, both clinically and statistically, with fracture prosthesis than with nonoperative treatment. However, the reliability of EQ-5D in the assessment of HRQoL in patients with a proximal humeral fracture is controversial. [@CIT0021] reported good internal and external responsiveness of EQ-5D in patients with a proximal humeral fracture. In contrast, [@CIT0024] and [@CIT0023] found a substantial ceiling effect, which limits the reliability of this instrument. Thus, the results of [@CIT0019] must be interpreted with caution. In addition, they did not find any significant differences in mean functional shoulder scores between the 2 groups. Up to 20% of patients in the nonoperative group had non-union, whereas tuberculum malposition was detected in 16% of the patients in the operative group. Non-union and tuberculum malposition compromise clinical results and lead to poor range of movement (ROM).

Comparison of surgical alternatives {#ss6}
-----------------------------------

The functional outcomes favored the Epoca prosthesis over the HAS prosthesis. Both groups had very few complications. However, 1-year follow-up is too short for detection of loosening, detection of wear, and determination of prosthesis survival. Some studies have addressed the treatment of complicated proximal humerus fractures with reverse prostheses ([@CIT0006], [@CIT0004]), but there have been no high-quality trials to match the inclusion criteria of our review. No differences were found in function or complication rate between patient groups in whom monoaxial or polyaxial screws were used with the locking plate. Comparing MIROS pinning and traditional pinning, MIROS gave better functional results and a lower complication rate. All of the results comparing 2 surgical alternatives are from publications with a high risk of bias.

We realize that the criteria used in our review are tight, excluding trials that may have potential clinical significance, but our primary aim was to collect evidence for treatment of elderly patients with proximal humerus fracture. Although we initially limited inclusion to patients aged 60 years or more, we decided to include 3 papers with some younger patients ([@CIT0007], [@CIT0019], b). However, the mean age of the patients in these studies was 74--77 years. Leaving these 3 rather good-quality trials out of the analysis would have left us with too few trials to draw any conclusions from, so they were included according to the PRISMA recommendations acknowledging the need for an iterative process in some systematic reviews ([@CIT0017]). Another limitation may be related to uncertain classifications systems, and therefore unknown patient recovery for distinct fracture types ([@CIT0016]). 3 publications had a high risk of bias. As the publications in this review were heterogeneous regarding patient groups, interventions, and outcome measures, a meta-analysis was not justified.

The Cochrane library published the latest systematic review on this subject in December 2012 ([@CIT0012]). They concluded that, "There is insufficient evidence to inform the management of these fractures". The difference with our analysis is that we set the age limit at 60 years and older, and we had criteria for the appropriate group sizes. Furthermore, our analysis includes papers by [@CIT0009], [@CIT0001], and [@CIT0003], which were published after the Cochrane review. According to the trial registries (clinicaltrials.com, controlled-trials.com), there are currently 5 trials enrolling patients to compare operative and nonoperative treatment.

In summary, there are too few trials for a solid evidence base. Furthermore, 3 of the publications had a high risk of bias, but these papers assessed differences between 2 operative treatments and did not provide evidence for the main question: whether to use operative or nonoperative treatment. However, there is some weak evidence in favor of nonoperative treatment over surgery with locking plate systems and tension banding. 2 trials have provided weak to moderate evidence that for 4-part fractures, shoulder function is not better with hemiarthroplasty than with nonoperative treatment. One of the trials has provided limited evidence that health-related quality of life may be better at 2-year follow-up after hemiarthroplasty. With high complication rates for all operative treatments, these should not be considered to be the gold standard in the treatment of proximal humerus fractures.

Supplementary data {#ss7}
------------------

[Table 4](#s1){ref-type="supplementary-material"} and Appendix are available at Acta's website ([www.actaorthop.org](www.actaorthop.org)), identification number 7918.

###### 

Click here for additional data file.
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